Venari Medical announces publication of pre-clinical data in

/PRNewswire/ -- InVera Medical are delighted to announce the publication of its pre-clinical feasibility study of the InVera minimally invasive, exclusively

Spark Crowdfunding: The Top 100 Most Ambitious Companies in Ireland - 2023 by SparkCrowdfunding - Issuu

Latest Advances in Clinical and Pre-Clinical Cardiovascular Magnetic Resonance Imaging

Latest news – BIBA Medtech Insights

enVVeno Medical (NVNO) Stock: Unique Exposure To Venous Treatment Domain

Navina secures $22M to process and summarize medical data for clinicians

Medical Device Outsourcing Market Size, Trends, Opportunities & Forecast

Obstetric Evidence Based Guidelines by Berghella, Vincenzo

Obstetric Evidence Based Guidelines (Series in Maternal-Fetal Medicine)

Panthera – supporting clinical research

Nerviano Medical Sciences to Present Preliminary Phase 1 PARP1 selective inhibitor data at the 35th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Nerviano Medical Sciences

Bridging clinical and real-world data

InnovationMap

Venari Medical announces publication of pre-clinical data in leading scientific journal Phlebology and changes name to InVera Medical™

Featured Case Report in Journal of Endovascular Therapy

Earlybird Venture Capital on LinkedIn: #ebvchealth #ebvclive #tbchcambridge #techbio #startups #networking

Venari Medical announces publication of pre-clinical data in leading scientific journal Phlebology and changes name to InVera Medical™